PharmaResources (Shanghai) Co., Ltd. (SHE:301230)
China flag China · Delayed Price · Currency is CNY
30.80
+0.02 (0.07%)
Sep 1, 2026, 4:00 PM EDT

SHE:301230 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
91.6159.1184.52204.3763.64108.44
Short-Term Investments
-4.494.534.966.364.33
Trading Asset Securities
190.35248.98251.77340.7910.650.4
Cash & Short-Term Investments
281.97312.58340.81550.05780.65113.17
Cash Growth
-18.64%-8.29%-38.04%-29.54%589.78%1.71%
Accounts Receivable
161.4151.35101.7986.2587.7492.35
Other Receivables
4.823.383.072.530.020.01
Receivables
166.22154.73104.8688.7887.7692.36
Inventory
73.3274.0569.0461.4251.0946.77
Prepaid Expenses
----1.65-
Other Current Assets
43.8140.7439.631.0815.3924.91
Total Current Assets
565.32582.1554.32731.32936.53277.21
Property, Plant & Equipment
321.78338.38359.83570.23254.66217.62
Long-Term Investments
77.4433.1720.0810.08-1.9
Other Intangible Assets
9.248.628.498.718.257.94
Long-Term Deferred Tax Assets
50.8247.230.8110.292.842.05
Long-Term Deferred Charges
266.82283.08318.97155.3371.0650.62
Other Long-Term Assets
11.0121.5623.931.1927.920.45
Total Assets
1,3021,3141,3161,4871,301557.81

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
52.2962.5652.12114.6139.7750.65
Accrued Expenses
39.5846.7834.6532.6134.3431.26
Short-Term Debt
5.7610.0110.0115.9210.0122.34
Current Portion of Leases
-25.9920.4118.769.869.09
Current Income Taxes Payable
0.981.020.923.332.217.46
Current Unearned Revenue
8.598.155.114.172.57.01
Other Current Liabilities
37.3917.72.191.812.180.85
Total Current Liabilities
167.8172.21125.4191.22100.87128.67
Long-Term Leases
115.45129.3151.29171.6780.4376.92
Long-Term Unearned Revenue
0.220.220.17---
Long-Term Deferred Tax Liabilities
5.284.163.313.632.510.06
Other Long-Term Liabilities
1.223.983.573.14.563.72
Total Liabilities
289.96309.87283.73369.62188.38209.37

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
180.94139.59139.59107.6276.8757.62
Additional Paid-In Capital
730.66772.93766.81798.77824.13146.08
Retained Earnings
146144.84179.32211.15211.97144.07
Treasury Stock
-45.09-53.08-53.08---
Comprehensive Income & Other
-0.05-0.040.06--0.080.66
Shareholders' Equity
1,0121,0041,0331,1181,113348.44
Total Liabilities & Equity
1,3021,3141,3161,4871,301557.81

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
144.4165.31181.71206.35100.3108.35
Net Cash (Debt)
137.56147.27159.11343.69680.354.82
Net Cash Growth
-15.66%-7.44%-53.71%-49.48%14005.50%-94.56%
Net Cash Per Share
0.740.790.861.904.730.04
Filing Date Shares Outstanding
177.32178.8178.8181.88181.88136.34
Total Common Shares Outstanding
177.32178.8178.8181.88181.88136.34
Working Capital
397.52409.88428.92540.1835.66148.54
Book Value Per Share
5.715.625.786.146.122.56
Tangible Book Value
1,003995.611,0241,1091,105340.5
Tangible Book Value Per Share
5.665.575.736.106.072.50
Buildings
-56.653.8853.8852.5648.86
Machinery
-281.61262.93228.35170.56126.61
Construction In Progress
-7.331.42199.9827.4224.77
Order Backlog
--311.78308.14365.31236.88